Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification

BackgroundNeuroblastoma (NB) is the most common extracranial solid tumor in children, accounting for approximately 15% of pediatric oncology mortality. While risk-stratified therapy has improved survival, high-risk cases still face poor outcomes. Pretreatment inflammatory markers, including the neut...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Lixiao Shi, Dixiao Zhong, Ruihong Tang, Duanfang Shao, Xiang Cheng, Zhaoxia Zhang, Rong Liu
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2026-06-01
سلاسل:	Frontiers in Immunology
الموضوعات:	neuroblastoma neutrophil-to-lymphocyte ratio (NLR) pediatric oncology platelet-to-lymphocyte ratio (PLR) prognostic biomarkers risk stratification
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1831234/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!